# Reversible Second-Degree Heart Block Attributed to Ondansetron: A Rare Side Effect

**Authors:** Abey Sebastian, Emmanuel Bhaskar, Swathy Moorthy, Lakshmi M

PMC · DOI: 10.7759/cureus.64109 · Cureus · 2024-07-08

## TL;DR

A pregnant woman developed a rare reversible heart block after receiving ondansetron, suggesting a possible link between the drug and cardiac rhythm disturbances.

## Contribution

Identifies ondansetron as a potential cause of reversible second-degree heart block in a clinical setting.

## Key findings

- The patient exhibited type 1 and type 2 Mobitz second-degree heart block after ondansetron administration.
- Heart block recurred after a second dose of ondansetron and resolved within 36 hours.
- The patient remained asymptomatic throughout the episode with stable ventricular rates.

## Abstract

A primigravida at 36 weeks with gestational diabetes mellitus and hypothyroidism and no prior chronic medical illness was admitted for safe confinement. A cesarean section was required to deliver the baby with breech presentation complicated by a slow progression of labor. Asymptomatic sinus bradycardia with a heart rate of 40 per minute was observed during the induction of anesthesia. Before bupivacaine administration for spinal anesthesia, she was administered pantoprazole 40 mg and ondansetron 4 mg intravenously. ECG recording showed a type 1 Mobitz second-degree heart block. Follow-up ECG showed progression of heart block to type 2 Mobitz second-degree heart block. The second-degree heart block persisted for 16 hours, during which the patient was asymptomatic, and the ventricular rate was maintained at a range of 60-80 per minute. After normalization of rhythm, the patient was observed in the ICU. She received another dose of ondansetron 4 mg intravenously for vomiting, and the heart block recurred. The rhythm disturbance was attributed to ondansetron. Her rhythm normalized after 36 hours, and she was subsequently discharged home three days later.

## Linked entities

- **Chemicals:** ondansetron (PubChem CID 4595), pantoprazole (PubChem CID 4679), bupivacaine (PubChem CID 2474)
- **Diseases:** gestational diabetes mellitus (MONDO:0005406), hypothyroidism (MONDO:0005420)

## Full-text entities

- **Diseases:** sinus bradycardia (MESH:D012804), Heart Block (MESH:D006327), hypothyroidism (MESH:D007037), vomiting (MESH:D014839), gestational diabetes mellitus (MESH:D016640)
- **Chemicals:** pantoprazole (MESH:D000077402), Ondansetron (MESH:D017294), bupivacaine (MESH:D002045)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11306193/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11306193/full.md

## References

19 references — full list in the complete paper: https://tomesphere.com/paper/PMC11306193/full.md

---
Source: https://tomesphere.com/paper/PMC11306193